[Lithium treatment and hyperparathyroidism].
BACKGROUND
Lithium treatment, which is extensively used in bipolar affective disorders, may give rise to hypercalcaemia and sometimes to irreversible hyperparathyroidism.


METHODS
We present a patient who developed hyperparathyroidism following long-term treatment with lithium.


RESULTS
After 15 years on lithium the patient was diagnosed with hypercalcaemia; at the same time the patient stopped her lithium medication. Two years later she developed depression with psychotic symptoms and was given electroconvulsive treatment. Measurements of serum calcium and parathormon showed that she had developed hyperparathyroidism. Neck exploration was performed, and two parathyroid adenomas (weight 650 mg and 880 mg), which had been detected by scintigraphy, were removed. Lithium treatment was restarted. One year later she was normocalcaemic and her mood was normal.


CONCLUSIONS
In lithium-induced hyperparamyroidism, lithium should be replaced with other mood stabilizers, preferably an antiepilepticum. If cessation of lithium therapy does not lead to normocalcaemia, parathyroidectomy is indicated.
Dieserud
F
F
Psykiatrisk spesialtjeneste Fylkesavdeling Tønsberg Postboks 2084 3103 Tønsberg. f-die@online.no
Brun
A C
AC
Låhne
P E
PE
Normann
E
E
D000928:Antidepressive Agents / Q000009:adverse effects*; D018692:Antimanic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced; D006962:Hyperparathyroidism, Secondary / Q000139:chemically induced*; D016651:Lithium Carbonate / Q000009:adverse effects*; D008875:Middle Aged
D000928:Antidepressive Agents; D018692:Antimanic Agents; D016651:Lithium Carbonate